LDNAM
ENZ

Lepercq De Neuflize Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Lepercq De Neuflize Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-156,303
Closed -$57.8K – 16
2025
Q1 		$57.8K Buy
156,303
+33,303
+27% +$18.4K 0.06% 8
2024
Q4 		$87.9K Buy
+123,000
New +$127K 0.06% 10

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Lepercq De Neuflize Asset Management's ENZ Position: Q2 2025 in Review

Lepercq De Neuflize Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 156,303 shares — an estimated $57.8K sold.

Lepercq De Neuflize Asset Management first reported a position in ENZ in Q4 2024 and held it in 2 quarters. The position peaked at $87.9K in Q4 2024. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Lepercq De Neuflize Asset Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Lepercq De Neuflize Asset Management sold 156,303 Enzo Biochem, Inc. shares in Q2 2025, an estimated $57.8K.
  • Lepercq De Neuflize Asset Management first reported a position in Enzo Biochem, Inc. in Q4 2024 and held it in 2 quarters.
  • Lepercq De Neuflize Asset Management's Enzo Biochem, Inc. position peaked at $87.9K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Lepercq De Neuflize Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.